Guangdong Taienkang Pharmaceutical Co., Ltd.

Informe acción SZSE:301263

Capitalización de mercado: CN¥6.2b

Guangdong Taienkang Pharmaceutical Resultados de beneficios anteriores

Pasado controles de criterios 1/6

Guangdong Taienkang Pharmaceutical has been growing earnings at an average annual rate of 12.4%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 7.4% per year. Guangdong Taienkang Pharmaceutical's return on equity is 6.6%, and it has net margins of 17.9%.

Información clave

12.4%

Tasa de crecimiento de los beneficios

2.9%

Tasa de crecimiento del BPA

Crecimiento de la industria Pharmaceuticals 10.9%
Tasa de crecimiento de los ingresos7.4%
Rentabilidad financiera6.6%
Margen neto17.9%
Última actualización de beneficios30 Sep 2024

Actualizaciones de resultados anteriores recientes

Weak Statutory Earnings May Not Tell The Whole Story For Guangdong Taienkang Pharmaceutical (SZSE:301263)

Sep 03
Weak Statutory Earnings May Not Tell The Whole Story For Guangdong Taienkang Pharmaceutical (SZSE:301263)

Recent updates

Weak Statutory Earnings May Not Tell The Whole Story For Guangdong Taienkang Pharmaceutical (SZSE:301263)

Sep 03
Weak Statutory Earnings May Not Tell The Whole Story For Guangdong Taienkang Pharmaceutical (SZSE:301263)

Guangdong Taienkang Pharmaceutical Co., Ltd.'s (SZSE:301263) P/E Still Appears To Be Reasonable

Aug 23
Guangdong Taienkang Pharmaceutical Co., Ltd.'s (SZSE:301263) P/E Still Appears To Be Reasonable

Here's Why Guangdong Taienkang Pharmaceutical (SZSE:301263) Can Manage Its Debt Responsibly

Jul 22
Here's Why Guangdong Taienkang Pharmaceutical (SZSE:301263) Can Manage Its Debt Responsibly

Guangdong Taienkang Pharmaceutical (SZSE:301263) Is Paying Out Less In Dividends Than Last Year

May 22
Guangdong Taienkang Pharmaceutical (SZSE:301263) Is Paying Out Less In Dividends Than Last Year

Guangdong Taienkang Pharmaceutical (SZSE:301263) Seems To Use Debt Quite Sensibly

Feb 26
Guangdong Taienkang Pharmaceutical (SZSE:301263) Seems To Use Debt Quite Sensibly

Desglose de ingresos y gastos

Cómo gana y gasta dinero Guangdong Taienkang Pharmaceutical. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

SZSE:301263 Ingresos, gastos y beneficios (CNY Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Sep 2475213520275
30 Jun 2475113720571
31 Mar 2475615420664
31 Dec 2376116020663
30 Sep 2379118921264
30 Jun 2381420620957
31 Mar 2379417322450
01 Jan 2378317521540
30 Sep 2275916819429
30 Jun 2271214019025
31 Mar 2269715716425
01 Jan 2265412016626
30 Sep 2166112417731
30 Jun 2166812717432
31 Mar 2167013316532
31 Dec 2070916115731
30 Sep 2066213814833
30 Jun 2061211913330
31 Mar 205658713027
31 Dec 194965511724
30 Sep 194965610619
30 Jun 195126910520
31 Mar 19523769920
31 Dec 185147410020
30 Sep 18486719820
30 Jun 18480679720
31 Mar 18457588928
31 Dec 17450558924
30 Sep 17430438719
30 Jun 17408358614
31 Mar 1737831900
31 Dec 1636728900
30 Sep 1638238900
30 Jun 1639849900
31 Mar 1638445820
31 Dec 1537042750
30 Sep 1533736650
30 Jun 1530429560
31 Mar 1530535550
31 Dec 1430440520
31 Dec 1328048440

Ingresos de calidad: 301263 has a high level of non-cash earnings.

Margen de beneficios creciente: 301263's current net profit margins (17.9%) are lower than last year (23.9%).


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: 301263's earnings have grown by 12.4% per year over the past 5 years.

Acelerando crecimiento: 301263's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Beneficios vs. Industria: 301263 had negative earnings growth (-28.8%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-1.2%).


Rentabilidad financiera

Alta ROE: 301263's Return on Equity (6.6%) is considered low.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado